User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
 Views 15
 Downloands 2
Determination of risk factors using Nonlinear Principal Component Analysis in patients with breast tumour
2021
Journal:  
Medical Science and Discovery
Author:  
Abstract:

Objective: Breast cancer, which is the most common among women in the world and constitutes approximately 30% of all cancers, takes places near the top among the diseases that threaten women's health. The purpose of this study is to determine the risk factors in patients with breast tumours using nonlinear principal component analysis. Materials and Methods: During the application process, a data set of 569 (357 benign, 212 malign) patients with breast tumours was used. To find independent features, the data set was reduced to two dimensions via nonlinear principal component analysis. The results were evaluated by comparing the success of the method with the ROC curve. Results: The cut-off values for the radius, perimeter, area, smoothness and texture of the tumour were 14.19, 656.10, 0.09, 2.87 and 0.11, respectively. The sensitivity of the current values according to the results of ROC analysis was determined as 84% for radius, 80% for perimeter, 86% for the area and 94% for texture. It is seen that the method has an overall success of over 80% in detecting malignant tumours. Conclusions: It is hoped that this method, which is used to reveal risk factors and identify distinctive features in breast tumours, will reduce medical costs and provide a second opinion to physicians. In terms of decision making, it is predicted that the method can recognize malignant tumours and reduce the need for unnecessary biopsy for benign tumours.

Keywords:

2021
Author:  
Citation Owners
Information: There is no ciation to this publication.
Similar Articles












Medical Science and Discovery

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 743
Cite : 80
Medical Science and Discovery